Answer
Jan 20, 2025 - 02:45 PM
Tirzepatide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with Multiple Endocrine Neoplasia syndrome type 2. Additionally, people with a known hypersensitivity to tirzepatide or any of its components should avoid using it. For further consultation, you can contact us at our toll-free number, 1-800-891-0844, or chat with us online. We are available 24 hours a day, 7 days a week.
